US Stock Market Move | Adjusted EPS for Q4 exceeds market expectations, CVS Health Corporation (CVS.US) rose more than 9% in pre-market trading.
On Wednesday, CVS Health (CVS.US) rose over 9% in pre-market trading to $60.10.
On Wednesday, CVS Health Corporation (CVS.US) rose more than 9% in pre-market trading, reaching $60.10. On the news front, the company's adjusted diluted earnings per share for the fourth quarter were $1.19, exceeding analysts' expectations of $0.91 according to FactSet. Quarterly revenue was $97.71 billion, an increase from $93.81 billion in the same period last year, surpassing analysts' expectations of $97.09 billion from FactSet. For 2025, the company expects adjusted diluted earnings per share to be between $5.75 and $6.00, while FactSet analysts had predicted $5.86.
Related Articles

New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


